Hypomagnesemia in Chronic Kidney Disease Stage 5
Journal Title: Нирки - Year 2016, Vol 1, Issue 15
Abstract
The article describes the clinical case of correction of hypomagnesemia in a patient 49 years with chronic kidney disease stage 5 with application magnesium orotate.
Authors and Affiliations
Z. V. Babenko
Chronic kidney disease and anemia: application of ferrous bisglycinate chelate for correction of iron deficiency in patients with chronic kidney disease
Anemia is a component of chronic kidney disease, having erythropoietin- and iron deficiency nature. 2012 KDIGO guidelines determine anemia as a hemoglobin concentration < 120 g/l in women and < 130 g/l in men. An iron de...
2017 World Kidney Day in Ukraine
.
Renin angiotensin-aldosterone system blockers: chronic kidney disease and cardiovascular risk
Reducing the risk of cardiovascular events is one of the most topical issues of modern medicine. Patients with chronic kidney disease stage 3 or lower, according to international guidelines, refer to the group with high...
Kidney Damage in Hemorrhagic Vasculitis Occurring in Childhood and Adulthood
Introduction. Nephropathy is diagnosed in 30–60 % of patients with hemorrhagic vasculitis (HV) (Schönlein Henoch puprupa) and occurred in each fourth of them in the onset of the disease and with the same incidence at fir...
ABO-incompatible kidney transplantation: historical aspects and actual ways of solving the problem (literature review)
.